Dominik Wolf

Increase of regulatory T cells in the peripheral blood of cancer patients.

Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.

Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.

Endothelial progenitor cells: a source for therapeutic vasculogenesis?

CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.

Re: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.

Letters regarding article by Wojakowski et al, "mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction".

RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines.

Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features.

CD4CD25 regulatory T cells: a new treatment option in glomerulonephritis.

The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation.

Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice.

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

Complete or partial trisomy 3 in gastro-intestinal MALT lymphomas co-occurs with aberrations at 18q21 and correlates with advanced disease stage: a study on 25 cases.

Immune cells in colorectal cancer.

CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application.

Regulatory T cells in cancer biology: a possible new target for biochemical therapies.

The effect of zoledronic acid on the function and differentiation of myeloid cells.

Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure.

Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation.

Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors.

Role of forkhead box protein 3 expression in invasive breast cancer.

Myocardial ischaemia-reperfusion injury in haematopoietic cell-restricted beta1 integrin knockout mice.

Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia.

Mesenchymal stem cells as cellular immunosuppressants.

Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.

Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.

The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo.

Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.

A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours.

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.

High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.

Comment on "Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice".

High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer.

Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer.

The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism.

First annual report of the Austrian CML registry.

Role of gene-expression profiling in chronic myeloid leukemia.

IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression.

Special edition myeloproliferative neoplasia - disease pathogenesis and treatment options.

Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.

Dose escalation of imatinib in chronic-phase chronic myeloid leukemia patients: is it still reasonable?

Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats.

High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer.

State dependent posterior hippocampal volume increases in patients with major depressive disorder.

Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions.

Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy.

Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.

Novel treatment concepts for graft-versus-host disease.

Osteoderm histology of the Pampatheriidae (Cingulata, Xenarthra, Mammalia): Implications for systematics, osteoderm growth, and biomechanical adaptation.

Ex vivo leukemia models and their potential clinical relevance.

DyeCycle Violet used for side population detection is a substrate of P-glycoprotein.

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.

Releasing the brake: targeting Cbl-b to enhance lymphocyte effector functions.

Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantation.

Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model.

Structural integrity of the corpus callosum predicts long-term transfer of fluid intelligence-related training gains in normal aging.

Engineering effective T-cell based antitumor immunity.

The role of the e3 ligase cbl-B in murine dendritic cells.

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo.

Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.

Advances in immunotherapy of chronic myeloid leukemia CML.

Age-related increases in Stroop interference: delineation of general slowing based on behavioral and white matter analyses.

Medical decision analysis for first-line therapy of chronic myeloid leukemia.

Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?

Systematic assessment of decision-analytic models for chronic myeloid leukemia.

Hearing assessment in dental practitioners and other academic professionals from an urban setting.

Association of structural global brain network properties with intelligence in normal aging.

The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.

Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2.

Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.

Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma.

Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning.

The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics.

Harmonized benchmark labels of the hippocampus on magnetic resonance: the EADC-ADNI project.

The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors.

Remission of recalcitrant dermatomyositis treated with ruxolitinib.

Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.

Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.

Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project.

OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.

Another piece of the puzzle--optimal TKI selection before treatment discontinuation in CML.

More on remission of recalcitrant dermatomyositis treated with ruxolitinib.

Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.

JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms.

JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms.

Treg(s) in Cancer: Friends or Foe?

CCR 20th Anniversary Commentary: From Regulatory T Cells to Checkpoint Monoclonal Antibodies--Immuno-oncology Advances Clinical Cancer Research.

Differential associations of age with volume and microstructure of hippocampal subfields in healthy older adults.

Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.

Altered whole-brain white matter networks in preclinical Alzheimer's disease.

When and how to 'FLAMSA-RIC' in acute myeloid leukemia?

Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.

The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance.

Non-Linear Association between Cerebral Amyloid Deposition and White Matter Microstructure in Cognitively Healthy Older Adults.

NK cell modulation by JAK inhibition.

Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging.

Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype.

Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL.

Effectiveness of Self-Hypnosis on the Relief of Experimental Dental Pain: A Randomized Trial.

JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus.

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy.

Primary Urethral Plasmacytoma Treated with High-Dose-Rate Brachytherapy: A Case Report.

Get a grip on immune cells by inhibiting JAKs.

γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm.

High prevalence of side population in human cancer cell lines.

Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions.

Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.

Antigen-presenting human B cells are expanded in inflammatory conditions.

Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation.

Hypnosis and Local Anesthesia for Dental Pain Relief-Alternative or Adjunct Therapy?-A Randomized, Clinical-Experimental Crossover Study.

Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.

JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus.

Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML.

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia.

JAK/STAT disruption induces immuno-deficiency: Rationale for the development of JAK inhibitors as immunosuppressive drugs.

Daptomycin for Complicated Skin Infections: A Randomized Trial.

Reference standard space hippocampus labels according to the EADC-ADNI harmonized protocol: Utility in automated volumetry.